RESEARCH FOUNDATIONS COLLABORATE TO FUND REPOSITORY OF PROMISING CNS ACTIVE COMPOUNDS
Date: 28 February 2013
Description:
The Alzheimer’s Drug Discovery Foundation
(ADDF), Beyond Batten Disease Foundation
(BBDF) and the National Multiple Sclerosis Society today announced a funding collaboration to support the creation of the Collaborative CNS Screening Initiative (CCSI), a central repository of chemical compounds that have shown significant Central Nervous System (CNS) activity. Led by the Harvard
NeuroDiscovery Center’s Laboratory for Drug Discovery in Neurodegeneration (LDDN), at Brigham and Women’s Hospital, the CCSI will share emerging compounds with the potential
to treat diseases of the CNS among academic CNS drug discovery centers to maximize their potential and accelerate drug discovery efforts within the neuroscience community.
Source: ADDF
Contact Name: Amanda Mulally
Contact E-mail: amulally@kynecommunications.com
Contact Phone Number: 206-910-4969